Login
$CTTH
$0.05 -$0.00 (3.06%) Close

$CTTH SEC Filings

Filed On Filing
26 Oct 2026 Form 4: Ctt Pharmaceutical HOLDINGS, Inc., Director

Bought 5,880 shares ($335)

19 Oct 2026 Form 4: Ctt Pharmaceutical HOLDINGS, Inc., Director

Bought 2,000 shares ($114)

13 Oct 2026 FORM 8-A12G
09 Oct 2026 8-K: Changes in Registrant's Certifying Accountant

We are the predecessor independent registered public accounting firm for CTT Pharmaceutical Holdings, Inc. (the Company). We have read the Company's disclosure in Item 4.01 of the Company's Current Report on Form 8-K dated October 2, 202...

07 Oct 2026 8-K: Changes in Registrant's Certifying Accountant

Dear CTT Pharmaceutical Holdings, Inc. Management and Those Charged with Governance:

06 Oct 2026 Form 4: Ctt Pharmaceutical HOLDINGS, Inc., Director

Bought 3,700 shares ($204)

29 Sep 2026 Form 4/A: Ctt Pharmaceutical HOLDINGS, Inc., Director

Bought 10,100 shares ($455)

28 Sep 2026 Form 4: Ctt Pharmaceutical HOLDINGS, Inc., Director

Bought 3,400 shares ($187)

23 Sep 2026 8-K: Entry into a Material Definitive Agreement; Other Events
22 Sep 2026 Form 4: Ctt Pharmaceutical HOLDINGS, Inc., Director

Bought 10,100 shares ($455)

17 Sep 2026 FORM 10-Q
16 Sep 2026 Form 4: Ctt Pharmaceutical HOLDINGS, Inc., Director

Bought 10,900 shares ($523)

10 Sep 2026 Form 4: Ctt Pharmaceutical HOLDINGS, Inc., CEO

Bought 3,500 shares ($175)

04 Sep 2026 Form 4: Ctt Pharmaceutical HOLDINGS, Inc., CEO

Bought 9,800 shares ($479)

02 Sep 2026 Form 4: Ctt Pharmaceutical HOLDINGS, Inc., CEO

Bought 3,000 shares ($147)

31 Aug 2026 Form 4: Ctt Pharmaceutical HOLDINGS, Inc., CEO

Bought 3,500 shares ($172)

24 Aug 2026 Form 4: Ctt Pharmaceutical HOLDINGS, Inc., CEO

Bought 2,100 shares ($116)

20 Aug 2026 Form 4: Ctt Pharmaceutical HOLDINGS, Inc., CEO

Bought 11,500 shares ($518)

19 Aug 2026 Form 4: Ctt Pharmaceutical HOLDINGS, Inc., CEO

Bought 10,000 shares ($590)

14 Aug 2026 Form 4: Ctt Pharmaceutical HOLDINGS, Inc., CEO

Bought 1,800 shares ($112)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support